A novel formulation of calcipotriene (CAL), betamethasone dipropionate (BDP) cream was found to be more effective, provide superior quality of life, and safe in patients with psoriasis, compared with ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Wynzora® Cream will be available to US patients from 12 July 2021. CHARLESTON, SC / ACCESSWIRE / July 6, 2021 / EPI Health announced today the publication of two posters featuring data from the head ...

Akorn, a leading specialty pharmaceutical company, has received the Food and Drug Administration’s clearance for betamethasone dipropionate lotion (augmented), 0.05%. Betamethasone dipropionate lotion ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

– New data analysis from previously completed successful Phase 3 study 1 demonstrated WYNZORA ® Cream to be effective and convenient for skin of color patients for the treatment of plaque psoriasis ...

WAILEA, Hawaii — A combination calcipotriene and betamethasone dipropionate cream showed similar efficacy in treating plaque psoriasis in patients with skin of color as it did in the full trial ...

Wynzora is a combination of calcipotriene, a synthetic vitamin D3 analogue, and betamethasone dipropionate, a corticosteroid. Wynzora ® Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064 ...

Wynzora Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) for once-daily topical treatment of plaque psoriasis in adults 18 years of age or ...

LAKE FOREST, Ill., Oct. 14, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced that it received a new Abbreviated New Drug Application ...

BUENA, N.J., Feb. 14, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s ...

Glenmark Pharmaceuticals, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for clotrimazole and betamethasone dipropionate cream USP, one per ...